Corona virus disease 2019 (COVID-19) is a public health emergency of international concern. The global population lacks immunity to COVID-19 and is generally susceptible. Underlying conditions, especially chronic respiratory diseases, may affect progression, treatment and prognosis of COVID-19. The majority of people who exposed to COVID-19 suffer only mild respiratory symptoms like cough, cold, difficulty in breathing, etc and these symptoms were correlated with Kaba Suram in the Siddha

more »

... ure. Case Summary: Siddha Clinical Research Unit, New Delhi (CCRS), Ministry of AYUSH, Govt. of India had reported a patient with confirmed COVID-19 by RT-PCR with bronchial asthma as a co-morbid condition. Recovery time from disease onset to negative test for COVID-19 was 19 days. Conclusion: Since the patient residing in Dwaraka, New Delhi has bronchial asthma as a co-morbid condition, both air pollution and the winter season are likely to increase the severity of the disease. But it was observed that the patient's condition did not deteriorate, so it could be presumed that the management of COVID-19 with the given Siddha internal medicines and external therapies as a standalone treatment ceased the progress of the disease to a severe stage. Key words: Bronchial Asthma, Corona virus, COVID-19, Kaba Suram, Siddha Medicine.